Delivery Order SPE2DB22D1106-SPE2DB25FDVF7
Award Date
1/21/25
Potential Completion Date
1/22/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Quillivant XR 25 mg/5 ml oral suspension in 60 ml bottles. The contract has a firm fixed price of $1,524.36 and a completion date of September 11, 2024. It is not a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the provision of Quillivant XR 25 mg/5 ml suspension in 60 ml bottles, with a ceiling value of $2,182.28 and a completion date of July 2, 2025. The contract is a firm fixed-price, non-set-aside award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,799.95, is for the supply of Quillivant XR 25 mg/5 ml suspension in 120 ml bottles. The contract has a firm fixed price pricing type and an ultimate completion date of August 11, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Quillivant XR, a 25 mg/5 ml suspension medication in 120 ml bottles. The contract has a ceiling value of $2,345.76 and a period of performance through June 11, 2025. This is a firm-fixed-price delivery order contract, which is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product, with a ceiling value of $2,145.24 and a period of performance through February 14, 2025. The contract is a firm fixed-price delivery order, and does not have a set-aside designation. AmerisourceBergen holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Quillivant XR 25 mg/5 ml suspension in 120 ml bottles. The contract has a ceiling value of $3,265.31 and a completion date of February 19, 2025. It is a firm fixed price contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Quillivant XR medication. The contract has a ceiling value of $1,863.00 and is a firm fixed-price delivery order with a final completion date of September 11, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Quillivant XR 25 mg/5 ml suspension, a prescription medication. The contract has a ceiling value of $3,538.78 and a period of performance ending on May 28, 2025. It is a firm fixed-price contract, indicating that the pricing is not subject to adjustment. The contract is not designated as a set-aside, meaning it...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Quillivant XR 25 mg/5 ml suspension, a prescription medication, with a ceiling value of $1,359.75 and a period of performance through November 14, 2024. The contract is a firm fixed-price delivery order and was not set aside for any specific business type. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Quillivant XR, a 25 mg/5 ml suspension medication, with a total ceiling value of $2,574.36 and a performance period ending on May 20, 2025. The contract is a firm-fixed-price delivery order and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...